{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-105369","form_type":"8-K","ticker":"VSEE","cik":"0001864531","company_name":"VSEE HEALTH, INC.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.897789+00:00","generated_at":"2026-06-10T07:06:18.320037+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Digital Health Acquisition Corp. receives Nasdaq delisting notice for failure to meet $50M MVLS standard","bullets":["Nasdaq Staff notified company on Sept 28, 2023 of delisting determination due to MVLS below $50M for 30 consecutive trading days.","Company had 180-day cure period ending Sept 27, 2023 but failed to regain compliance with MVLS Rule 5450(b)(2)(A).","Company intends to request a hearing by Oct 5, 2023 to stay suspension; securities may continue trading until panel decision.","Company may apply to transfer listing to Nasdaq Capital Market if it meets continued listing requirements there.","There is no assurance the hearing panel will grant a stay or that the transfer to NasdaqCM will be approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-105369","json":"https://secwatch.observer/filing/0001104659-23-105369.json","markdown":"https://secwatch.observer/filing/0001104659-23-105369.md","text":"https://secwatch.observer/filing/0001104659-23-105369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923105369/0001104659-23-105369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923105369/tm2327260d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:06:18.320037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"60e969c69b84de834cec951271d5170554b39c26","claim":"VSEE HEALTH, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).","evidence_excerpt":"d Warrants) (the “Securities”) because it has not regained compliance with the Market Value of Listed Securities (“MVLS”) Standard. The market value of the Company’s listed Securities was below the $50,000,000 minimum MVLS requirement for continued listing on Nasdaq Global under Nasdaq Listing Rule 5450(b)(2)(A) (the “MLVS Rule”) and had not been at least $50,000,000 for the proceeding 30 consecutive trading days. As previously reported by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 6, 2023, the Staff initially notified t","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465923105369/0001104659-23-105369-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}